The class of Snf5 activators primarily includes chemicals that modulate epigenetic mechanisms, particularly through the inhibition of DNA methylation and histone deacetylation. These compounds do not activate Snf5 directly but rather influence the chromatin environment, which is integral to the functional role of Snf5 in chromatin remodeling and gene regulation. The primary mechanism of these activators involves the inhibition of enzymes responsible for adding methyl groups to DNA (DNA methyltransferases) or removing acetyl groups from histones (histone deacetylases, HDACs). This action results in a more relaxed chromatin structure, enhancing the accessibility of transcription factors and the SWI/SNF complex, of which Snf5 is a crucial component, to DNA.
The impact of these activators on chromatin structure is crucial for understanding their indirect role in activating Snf5. By inhibiting DNA methylation and histone deacetylation, these compounds can lead to an increase in gene expression, including genes that may be regulated or influenced by the SWI/SNF complex. The relaxed chromatin state can facilitate the binding of the SWI/SNF complex to DNA, thereby enhancing the transcriptional regulatory roles of Snf5. Additionally, the altered expression of genes involved in cell cycle regulation, apoptosis, and other critical cellular processes, as a consequence of these epigenetic changes, can further influence the biological context in which Snf5 operates.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor, which leads to decreased DNA methylation and can indirectly affect chromatin remodeling. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
A histone deacetylase inhibitor that promotes acetylation of histones, influencing chromatin structure and potentially affecting Snf5-mediated gene regulation. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Another histone deacetylase inhibitor, which can lead to altered chromatin conformation and potentially impact Snf5 functions. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
A potent histone deacetylase inhibitor, affects chromatin architecture and gene expression, potentially influencing Snf5 activity. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $218.00 $634.00 | 1 | |
A histone deacetylase inhibitor known to alter chromatin structure and gene expression, possibly affecting Snf5-related pathways. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
A selective histone deacetylase inhibitor, can modify chromatin structure and indirectly influence Snf5 function. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
A histone deacetylase inhibitor with broader effects, possibly affecting chromatin remodeling and indirectly Snf5 activity. | ||||||
Mocetinostat | 726169-73-9 | sc-364539 sc-364539B sc-364539A | 5 mg 10 mg 50 mg | $214.00 $247.00 $1463.00 | 2 | |
Targets histone deacetylase, modifying chromatin structure, which may influence Snf5 activity. | ||||||
Belinostat | 414864-00-9 | sc-269851 sc-269851A | 10 mg 100 mg | $156.00 $572.00 | ||
A histone deacetylase inhibitor, impacts chromatin architecture, potentially affecting Snf5 function. | ||||||
Sirtinol | 410536-97-9 | sc-205976 sc-205976A | 1 mg 5 mg | $38.00 $113.00 | 14 | |
An inhibitor of sirtuin histone deacetylases, potentially influencing chromatin structure and indirectly Snf5 activity. | ||||||